• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Drug Discovery Informatics Market Report Research Report - Forecast Till 2030 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Drug Discovery Informatics Market

    ID: MRFR/Pharma/6360-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Drug Discovery Informatics Market Research Report Information By Product (Discovery Informatics, Development Informatics), Mode (In-House Informatics and Outsourced Informatics), Service (Sequencing and Target Data Analysis, Docking, Molecular Modeling, Clinical Trial Data Management and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Drug Discovery Informatics Market Report Research Report - Forecast Till 2030 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Drug Discovery Informatics Market Summary

    The Global Drug Discovery Informatics Market is projected to grow from 3.8 USD Billion in 2024 to 10.2 USD Billion by 2035.

    Key Market Trends & Highlights

    Drug Discovery Informatics Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 9.4% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 10.2 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 3.8 USD Billion, reflecting the increasing demand for drug discovery solutions.
    • Growing adoption of advanced data analytics due to the need for efficient drug development processes is a major market driver.

    Market Size & Forecast

    2024 Market Size 3.8 (USD Billion)
    2035 Market Size 10.2 (USD Billion)
    CAGR (2025-2035) 9.4%

    Major Players

    Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, Dassault Systèmes

    Drug Discovery Informatics Market Trends

    The growing chronic illness burden is driving the market growth

    The rising chronic illness burden drives Market CAGR for Drug Discovery Informatics. Rising R&D spending, increased funding for studies, especially in rare diseases, and increased use of bioinformatics in the development of drugs are driving market growth. The cost of discovering drugs, studying, and developing them is increasing dramatically. Most medication clinical trials are funded by pharmaceutical companies, which spend hundreds of millions of USD on drug development. Other factors propelling the drug discovery informatics business include pharmaceutical corporations' increasing involvement in a drug study and a pressing need to reduce the development and discovery of drugs expenses. 

    Given that technologies based on data remain in their early stages, they are expected to expand rapidly. In addition, certain benefits offered by drug delivery informatics remedies, including enhanced drug discovery procedure storing and extraction, knowledge organization, and immediate information that may be utilized in making decisions, are projected to propel the worldwide drug discovery informatics marketplace throughout forecasting.

    Additionally, it assists clients in making key decisions regarding optimizing drug safety and efficacy profiles. Businesses are also progressively implementing informatics technologies to reduce the lengthy drug research schedule. Curve Therapeutics Ltd., for example, will use the CDD Vault system to manage its biologically coded Microcycle technology in December 2020. It is a widely used hosted platform for applications in medicine, biotechnology, and educational institutions for the secure and frictionless exchange of data in actual time, encouraging cooperative discoveries.

    The  acceleration of Covid-19 drug discovery is helping to market growth. For example, scientists used virtual testing using drugs from the DrugBank to target viral proteins and human ACE2 receptors to provide quick answers. This research used silico techniques to identify small compounds that could be used in drug discovery against Covid-19. Similarly, firms are creating various digital services and solutions to aid in the various stages of developing drugs for Covid-19.

    For instance, Novartis funded around USD 59 million to spend on underserved illness study and development in 2021, based on the 2021 Annual report, as identified by the Access to Medicine Foundation as research and development areas of greatest need. As an outcome of these expenditures, many formerly fatal diseases are now controllable and even treatable, and this pattern is projected to continue, driving growth. Thus, it is anticipated that demand for Drug Discovery Informatics will increase throughout the projected timeframe due to the rising chronic illness burden. Thus, driving the Drug Discovery Informatics market revenue.

    The integration of advanced computational techniques in drug discovery is transforming the landscape of pharmaceutical research, enhancing efficiency and precision in the development of new therapeutics.

    U.S. National Institutes of Health

    Drug Discovery Informatics Market Drivers

    Market Growth Projections

    The Global Drug Discovery Informatics Market Industry is poised for substantial growth, with projections indicating a rise from 3.8 USD Billion in 2024 to 10.2 USD Billion by 2035. This trajectory suggests a compound annual growth rate (CAGR) of 9.4% from 2025 to 2035. The increasing complexity of drug discovery processes, coupled with the need for advanced informatics solutions, underpins this growth. As the industry evolves, stakeholders are likely to invest in innovative technologies that enhance efficiency and effectiveness in drug development.

    Increased Investment in R&D

    Increased investment in research and development (R&D) is a driving force behind the Global Drug Discovery Informatics Market Industry. Pharmaceutical companies and biotech firms are allocating substantial resources to innovate and develop new therapies. This trend is expected to propel the market from 3.8 USD Billion in 2024 to an estimated 10.2 USD Billion by 2035, reflecting a compound annual growth rate (CAGR) of 9.4% from 2025 to 2035. The focus on R&D not only fosters technological advancements but also enhances the overall efficiency of drug discovery processes.

    Rising Demand for Drug Development

    The Global Drug Discovery Informatics Market Industry experiences a notable surge in demand for drug development solutions. As pharmaceutical companies strive to accelerate the discovery process, the integration of informatics tools becomes essential. In 2024, the market is projected to reach 3.8 USD Billion, driven by the need for efficient data management and analysis. This trend reflects a broader shift towards data-driven decision-making in drug discovery, where informatics plays a pivotal role in optimizing research workflows and enhancing collaboration among stakeholders.

    Advancements in Computational Biology

    Advancements in computational biology significantly influence the Global Drug Discovery Informatics Market Industry. The emergence of sophisticated algorithms and machine learning techniques facilitates the analysis of complex biological data. These innovations enable researchers to identify potential drug candidates more efficiently, thereby reducing the time and cost associated with traditional methods. As the industry evolves, the integration of computational tools is expected to enhance predictive modeling and simulation capabilities, ultimately leading to more effective drug discovery processes.

    Growing Adoption of AI and Machine Learning

    The growing adoption of artificial intelligence (AI) and machine learning technologies is reshaping the Global Drug Discovery Informatics Market Industry. These technologies offer unprecedented capabilities in data analysis, enabling researchers to uncover insights from vast datasets. By automating routine tasks and enhancing predictive accuracy, AI and machine learning streamline the drug discovery process. As organizations increasingly recognize the potential of these technologies, their integration into informatics platforms is likely to accelerate, driving innovation and improving outcomes in drug development.

    Regulatory Compliance and Data Management Needs

    Regulatory compliance and the need for robust data management systems are critical drivers of the Global Drug Discovery Informatics Market Industry. As regulatory agencies impose stringent guidelines on data integrity and reporting, pharmaceutical companies must adopt comprehensive informatics solutions to ensure compliance. This necessity not only mitigates risks associated with regulatory breaches but also enhances the quality of data used in drug discovery. Consequently, the demand for informatics tools that facilitate efficient data management and regulatory adherence continues to grow, further propelling market expansion.

    Market Segment Insights

    Drug Discovery Informatics Product Insights

    The  Drug Discovery Informatics market segmentation, based on Product, includes Discovery Informatics and Development Informatics. The discovery informatics segment dominated the market, accounting for 63% of market revenue (USD 1.95 Billion) in 2022, owing to substantial attention on creating precise therapeutics. Precision medicine is tailoring healthcare to a patient's genetic and molecular profile.

    Drug Discovery Informatics Mode Insights

    The  Drug Discovery Informatics market segmentation, based on Modes, includes In-House Informatics and Outsourced Informatics. The outsourced informatics category generated the highest market revenue of about 51% (USD 1.6 billion) in 2022. Links between pharmaceutical corporations, contractual development, and manufacturing organizations are becoming more common. They develop reports on novel drug entities, which the sponsoring organization or drug manufacturer then utilizes for submission to the US FDA.

    Figure 1:  Drug Discovery Informatics Market, by Mode, 2024 & 2032 (USD Billion)

    Drug Discovery Informatics Market, by Mode, 2024 & 2032

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Drug Discovery Informatics Service Insights

    The  Drug Discovery Informatics market segmentation, based on Service, includes Sequencing and Target Data Analysis, Docking, Molecular Modeling, Clinical Trial Data Management and Others. The sequencing and target data analysis segment dominated the market, accounting for 43% of market revenue (USD 1.3 Billion) in 2022. Bioinformatic solutions are frequently used to create primary and secondary nucleic acid, protein, and other biomolecule sequencing libraries.

    Regional Insights

    By region, the research provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Drug Discovery Informatics market area will dominate this market during the projected timeframe; this is due to the existence of important market value participants and advanced healthcare infrastructure, as well as the expanding pharmaceutical and biotechnology businesses, as well as the development of next-generation genome sequencing and chemical labs which will boost the market growth in the North American region.

    Further, the major countries studied in the market report are the US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2:  Drug Discovery Informatics Market Share by Region 2024 (USD Billion)

    Drug Discovery Informatics Market Share by Region 2024

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Europe region’s Drug Discovery Informatics market accounts for the second-highest market share, attributable to the financial assistance offered by the authorities for developing and researching medications and the increase in therapeutic discovery initiatives. Further, the German Drug Discovery Informatics market holds the largest market share, and the UK Drug Discovery Informatics market is expected to grow and expand significantly in the European region during the projected timeframe.

    The Asia-Pacific Drug Discovery Informatics Market is expected to grow quickly during the projected timeframe. This is because of the region's expanding elderly population, rising prevalence of chronic illnesses, increased knowledge, and an increase in the number of clinical trials investigations. Moreover, China’s Drug Discovery Informatics market dominates the market share, and the Indian Drug Discovery Informatics market is expected to expand and grow steadily in the Asia-Pacific region during the projected timeframe.

    Key Companies in the Drug Discovery Informatics Market market include

    Industry Developments

    • Q2 2024: Inogen Launches Next-Generation Portable Oxygen Concentrator, the Inogen One G7 Inogen announced the commercial launch of its Inogen One G7 portable oxygen concentrator, featuring enhanced battery life and connectivity for remote patient monitoring, targeting both homecare and ambulatory use.
    • Q2 2024: Philips Receives FDA 510(k) Clearance for SimplyGo Mini Portable Oxygen Concentrator Upgrade Philips announced it has received FDA 510(k) clearance for an upgraded version of its SimplyGo Mini portable oxygen concentrator, which includes improved battery performance and a lighter design for increased patient mobility.
    • Q3 2024: Invacare Appoints New CEO to Drive Growth in Respiratory Product Segment Invacare Corporation announced the appointment of a new Chief Executive Officer, with a strategic focus on expanding its respiratory and oxygen concentrator business in North America and Europe.
    • Q2 2024: ResMed Acquires OxyMed for $120 Million to Expand Oxygen Therapy Portfolio ResMed completed the acquisition of OxyMed, an Australian manufacturer of medical oxygen concentrators, to strengthen its global respiratory care offerings and accelerate innovation in portable oxygen solutions.
    • Q1 2025: Teijin Opens New Medical Oxygen Concentrator Manufacturing Facility in Vietnam Teijin Limited inaugurated a new manufacturing facility in Vietnam dedicated to producing medical oxygen concentrators, aiming to meet rising demand in Southeast Asia and improve supply chain resilience.
    • Q2 2025: Chart Industries Secures Multi-Year Supply Contract with NHS for Oxygen Concentrators Chart Industries announced it has signed a multi-year contract to supply medical oxygen concentrators to the UK National Health Service (NHS), supporting hospital and homecare respiratory therapy programs.
    • Q3 2024: Nidek Medical India Launches Ultra-Portable Oxygen Concentrator for Indian Market Nidek Medical India introduced a new ultra-portable oxygen concentrator designed for the Indian market, featuring advanced filtration and energy-efficient operation for use in both urban and rural settings.
    • Q2 2024: Drive DeVilbiss Healthcare Announces Strategic Partnership with Medtronic for Oxygen Therapy Distribution Drive DeVilbiss Healthcare entered into a strategic partnership with Medtronic to distribute its line of medical oxygen concentrators across select European markets, expanding access to home-based respiratory care.
    • Q1 2025: Precision Medical Receives CE Mark for New High-Flow Oxygen Concentrator Precision Medical Inc. announced it has received CE Mark approval for its new high-flow oxygen concentrator, enabling commercial sales across the European Union and supporting critical care applications.
    • Q2 2025: O2 Concepts Raises $40 Million in Series C Funding to Accelerate Portable Oxygen Device Innovation O2 Concepts closed a $40 million Series C funding round to expand R&D and scale production of its next-generation portable oxygen concentrators, with a focus on smart, connected devices for homecare.
    • Q3 2024: Zhengzhou Olive Electronic Technology Wins Major Tender to Supply Oxygen Concentrators to Indonesian Hospitals Zhengzhou Olive Electronic Technology secured a government tender to supply thousands of medical oxygen concentrators to hospitals across Indonesia, supporting national healthcare infrastructure upgrades.
    • Q1 2025: Philips Launches Remote Monitoring Platform for Oxygen Concentrator Patients Philips introduced a new digital platform enabling remote monitoring and management of patients using its medical oxygen concentrators, aiming to improve outcomes and reduce hospital readmissions.

    Future Outlook

    Drug Discovery Informatics Market Future Outlook

    The Drug Discovery Informatics Market is projected to grow at a 9.4% CAGR from 2024 to 2035, driven by advancements in AI, increasing R&D investments, and the need for efficient drug development processes.

    New opportunities lie in:

    • Leverage AI-driven analytics to enhance predictive modeling for drug efficacy.
    • Develop cloud-based platforms for collaborative drug discovery across global teams.
    • Invest in data integration solutions to streamline multi-omics data analysis.

    By 2035, the Drug Discovery Informatics Market is expected to be a pivotal component of pharmaceutical innovation.

    Market Segmentation

    Drug Discovery Informatics Mode Outlook

    • In-house Informatics
    • Outsourced Informatics

    Drug Discovery Informatics Product Outlook

    • Discovery Informatics
    • Development Informatics

    Drug Discovery Informatics Service Outlook

    • Sequencing and Target Data Analysis
    • Docking
    • Molecular Modeling
    • Clinical Trial Data Management
    • Others

    Drug Discovery Informatics Regional Outlook

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 3.43 Billion
    Market Size 2024 USD 3.8004 Billion
    Market Size 2032 USD 7.8 Billion
    Compound Annual Growth Rate (CAGR) 9.40% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Mode, Service, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled  Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes
    Key Market Opportunities Product releases and R&D by significant critical players
    Key Market Dynamics Growing  emphasis on medication discoveryThere is a growing need to control medication discovery and development expenses.Increase in R&D spendingThe chronic illness burden is growing.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How much is the Drug Discovery Informatics market?

    The worldwide Drug Discovery Informatics market size was estimated at USD 3.43 Billion in 2023.

    What is the growth rate of the Drug Discovery Informatics market?

    The  market is estimated to grow and expand at a growth rate(CAGR) of 9.40% during the forecast timeframe.

    Which region holds the largest Drug Discovery Informatics market share?

    North America had the largest share of the  market

    Who are the key participants in the Drug Discovery Informatics market?

    The key participants in the Drug Discovery Informatics market are Thermo Fisher Scientific, PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

    Which Product led the Drug Discovery Informatics market?

    The Discovery Informatics category dominated the market in 2022.

    Which Mode had the largest market share in the Drug Discovery Informatics market?

    Outsourced Informatics had the largest share of the market.

    1. 'Table of Contents:
    2. Chapter 1 Report Prologue
    3. Chapter 2 Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Chapter 3 Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Chapter 4 Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Detection Technique
    6. Trends & Assessment
    7. Chapter 5 Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining Power
    8. of Suppliers
    9. Bargaining Power of Buyers
      1. Threat of New Entrants
        1. Threat of Substitutes
        2. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    10. Chapter 6 Global Drug
    11. Discovery Informatics Market, by Product
      1. Introduction
      2. Discovery Informatics
    12. Market Estimates & Forecast, by Region, 2020–2027
    13. Market Estimates &
    14. Forecast, by Country, 2020–2027
      1. Development Informatics
    15. Market Estimates & Forecast, by Region, 2020–2027
    16. Market Estimates &
    17. Forecast, by Country, 2020–2027
    18. Chapter 7 Global Drug Discovery Informatics Market, by Mode
      1. Introduction
      2. In-House Informatics
    19. Market Estimates &
    20. Forecast, by Region, 2020–2027
    21. Market Estimates & Forecast, by Country, 2020–2027
      1. Outsourced Informatics
    22. Market Estimates &
    23. Forecast, by Region, 2020–2027
    24. Market Estimates & Forecast, by Country, 2020–2027
    25. Chapter 8 Global Drug
    26. Discovery Informatics Market, by Service
      1. Introduction
      2. Sequencing and Target Data Analysis
    27. Market Estimates & Forecast,
    28. by Region, 2020–2027
    29. Market Estimates & Forecast, by Country, 2020–2027
      1. Docking
    30. Market Estimates &
    31. Forecast, by Region, 2020–2027
    32. Market Estimates & Forecast, by Country, 2020–2027
      1. Molecular Modeling
    33. Market Estimates &
    34. Forecast, by Region, 2020–2027
    35. Market Estimates & Forecast, by Country, 2020–2027
      1. Clinical Trial Data
    36. Management
    37. Market
    38. Estimates & Forecast, by Region, 2020–2027
    39. Market Estimates & Forecast, by Country, 2020–2027
      1. Others
    40. Market Estimates &
    41. Forecast, by Region, 2020–2027
    42. Market Estimates & Forecast, by Country, 2020–2027
    43. Chapter 9 Global Drug
    44. Discovery Informatics Market, by End User
      1. Introduction
      2. Pharmaceutical and Biotechnology Industries
    45. Market Estimates &
    46. Forecast, by Region, 2020–2027
    47. Market Estimates & Forecast, by Country, 2020–2027
      1. Contract Research
    48. Organizations (CROs)
    49. Market
    50. Estimates & Forecast, by Region, 2020–2027
    51. Market Estimates & Forecast, by Country, 2020–2027
      1. Others
    52. Market Estimates &
    53. Forecast, by Region, 2020–2027
    54. Market Estimates & Forecast, by Country, 2020–2027
    55. Chapter 10 Global Drug
    56. Discovery Informatics Market, by Region
      1. Introduction
      2. Americas
        1. North America
        2. Latin America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      5. Middle East &
    57. Africa
    58. Middle East
    59. Africa
    60. Chapter
    61. Company Landscape
    62. Introduction
    63. Market Share Analysis
    64. Key Developments & Strategies
    65. Chapter 12 Company Profiles
      1. Thermo Fisher Scientific, Inc.
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. PerkinElmer, Inc.
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. Certara, L.P.
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. Infosys Limited
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. Novo Informatics Pvt. Ltd.
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. Collaborative Drug
    66. Discovery Inc.
    67. Company Overview
    68. Product Overview
    69. Financial Overview
    70. Key Developments
    71. SWOT Analysis
    72. Key Strategies
    73. Selvita
    74. Company Overview
    75. Product Overview
    76. Financial Overview
    77. Key Developments
    78. SWOT Analysis
    79. Key Strategies
    80. Charles River Laboratories, Inc.
      1. Company Overview
        1. Product Overview
        2. Financial Overview
        3. Key Developments
        4. SWOT Analysis
        5. Key Strategies
      2. International Business Machines Corporation
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. Jubilant Life Sciences
    81. Ltd.
    82. Company Overview
    83. Product Overview
    84. Financial Overview
    85. Key Developments
    86. SWOT Analysis
    87. Key Strategies
    88. IO Informatics, Inc.
    89. Company Overview
    90. Product Overview
    91. Financial Overview
    92. Key Developments
    93. SWOT Analysis
    94. Key Strategies
    95. GVK Biosciences Private Limited
      1. Company Overview
        1. Product Overview
        2. Financial Overview
        3. Key Developments
        4. SWOT Analysis
        5. Key Strategies
      2. Dassault Systèmes
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
    96. Chapter 13 MRFR Conclusion
      1. Key Findings
        1. From CEO’s
    97. Viewpoint
    98. Unmet Needs of the Market
      1. Key Companies to Watch
      2. Predictions for the Drug Discovery Informatics Industry
    99. Chapter 14 Appendix
    100. Informatics Market Synopsis, 2020–2027
    101. Estimates and Forecast, 2020–2027 (USD Million)
    102. by Region, 2020–2027 (USD Million)
    103. –2027 (USD Million)
    104. (USD Million)
    105. Global Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)
    106. Informatics Market, by End User, 2020–2027 (USD Million)
    107. Informatics Market, by Product, 2020–2027 (USD Million)
    108. Informatics Market, by Mode, 2020–2027 (USD Million)
    109. Market, by Service, 2020–2027 (USD Million)
    110. Market, by End User, 2020–2027 (USD Million)
    111. Product, 2020–2027 (USD Million)
    112. –2027 (USD Million)
    113. (USD Million)
    114. US: Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)
    115. Discovery Informatics Market, by Product, 2020–2027 (USD Million)
    116. Discovery Informatics Market, by Mode, 2020–2027 (USD Million)
    117. Informatics Market, by Service, 2020–2027 (USD Million)
    118. Informatics Market, by End User, 2020–2027 (USD Million)
    119. Discovery Informatics Market, by Product, 2020–2027 (USD Million)
    120. Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)
    121. Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)
    122. Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)
    123. Discovery Informatics Market, by Product, 2020–2027 (USD Million)
    124. Discovery Informatics Market, by Mode, 2020–2027 (USD Million)
    125. Informatics Market, by Service, 2020–2027 (USD Million)
    126. Informatics Market, by End User, 2020–2027 (USD Million)
    127. Discovery Informatics Market, by Product, 2020–2027 (USD Million)
    128. Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)
    129. Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)
    130. Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)
    131. Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)
    132. Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)
    133. Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)
    134. Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)
    135. Drug Discovery Informatics Market, by Product, 2020–2027 (USD Million)
    136. Drug Discovery Informatics Market, by Mode, 2020–2027 (USD Million)
    137. Drug Discovery Informatics Market, by Service, 2020–2027 (USD Million)
    138. Drug Discovery Informatics Market, by End User, 2020–2027 (USD Million)
    139. & Africa: Drug Discovery Informatics Market, by Product, 2020–2027 (USD
    140. Million)
    141. Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2020–2027
    142. (USD Million)
    143. Middle East & Africa: Drug Discovery Informatics Market, by Service, 2020–2027
    144. (USD Million)
    145. Middle East & Africa: Drug Discovery Informatics Market, by End User, 2020–2027
    146. (USD Million)
    147. LIST
    148. OF FIGURES
    149. Research Process
    150. Segmentation for Global Drug Discovery Informatics Market
    151. Drug Discovery Informatics Market
    152. Global Drug Discovery Informatics Market Share, by Mode, 2020
    153. Informatics Market Share, by Service, 2020
    154. Share, by End User, 2020
    155. North America: Drug Discovery Informatics Market Share, by Country, 2020
    156. Discovery Informatics Market Share, by Country, 2020
    157. Market Share, by Country, 2020
    158. Share, by Country, 2020
    159. Thermo Fisher Scientific, Inc.: Key Financials
    160. Revenue
    161. Thermo Fisher Scientific, Inc.: Geographical Revenue
    162. Inc.: Segmental Revenue
    163. Financials
    164. Certara, L.P.: Segmental Revenue
    165. Key Financials
    166. Infosys Limited: Segmental Revenue
    167. Pvt. Ltd.: Key Financials
    168. Ltd.: Geographical Revenue
    169. Drug Discovery Inc.: Segmental Revenue
    170. Revenue
    171. Selvita: Key Financials
    172. Laboratories, Inc.: Key Financials
    173. Laboratories, Inc.: Geographical Revenue
    174. Financials
    175. International Business Machines Corporation: Segmental Revenue
    176. Machines Corporation: Geographical Revenue
    177. Sciences Ltd.: Segmental Revenue
    178. Inc.: Key Financials
    179. IO Informatics, Inc.: Segmental Revenue
    180. Private Limited: Key Financials
    181. Private Limited: Geographical Revenue
    182. Segmental Revenue
    183. Dassault Systèmes: Geographical Revenue'

    Market Segmentation

    Drug Discovery Informatics Product Outlook (USD Billion, 2018-2032)

    ·         Discovery Informatics

    ·         Development Informatics     

    Drug Discovery Informatics Mode Outlook (USD Billion, 2018-2032)

    ·         In-house Informatics 

    ·         Outsourced Informatics 

    Drug Discovery Informatics Service Outlook (USD Billion, 2018-2032)

    ·         Sequencing and Target Data Analysis

    ·         Docking

    ·         Molecular Modeling

    ·         Clinical Trial Data Management

    ·         Others 

    Drug Discovery Informatics Regional Outlook (USD Billion, 2018-2032)

    ·         North America Outlook (USD Billion, 2018-2032)

    o   North America Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   North America Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   North America Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   US Outlook (USD Billion, 2018-2032)

    o   US Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   US Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   US Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Canada Outlook (USD Billion, 2018-2032)

    o   Canada Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Canada Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Canada Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    ·         Europe Outlook (USD Billion, 2018-2032)

    o    Europe Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Europe Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Europe Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Germany Outlook (USD Billion, 2018-2032)

    o   Germany Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Germany Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Germany Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   France Outlook (USD Billion, 2018-2032)

    o   France Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   France Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   France Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   UK Outlook (USD Billion, 2018-2032)

    o   UK Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   UK Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   UK Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Italy Outlook (USD Billion, 2018-2032)

    o   Italy Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Italy Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Italy Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Spain Outlook (USD Billion, 2018-2032)

    o   Spain Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Spain Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics  

    o   Spain Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Rest Of Europe Outlook (USD Billion, 2018-2032)

    o   Rest Of Europe Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Rest Of Europe Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Rest Of Europe Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    ·         Asia-Pacific Outlook (USD Billion, 2018-2032)

    o    Asia-Pacific Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Asia-Pacific Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Asia-Pacific Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   China Outlook (USD Billion, 2018-2032)

    o   China Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   China Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   China Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Japan Outlook (USD Billion, 2018-2032)

    o   Japan Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Japan Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Japan Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   India Outlook (USD Billion, 2018-2032)

    o   India Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   India Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   India Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Australia Outlook (USD Billion, 2018-2032)

    o   Australia Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Australia Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Australia Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

    o   Rest of Asia-Pacific Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Rest of Asia-Pacific Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Rest of Asia-Pacific Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    ·         Rest of the World Outlook (USD Billion, 2018-2032)

    o    Rest of the World Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Rest of the World Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Rest of the World Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Middle East Outlook (USD Billion, 2018-2032)

    o   Middle East Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Middle East Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Middle East Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Africa Outlook (USD Billion, 2018-2032)

    o   Africa Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Africa Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Africa Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    o   Latin America Outlook (USD Billion, 2018-2032)

    o   Latin America Drug Discovery Informatics by Product

    §  Discovery Informatics

    §  Development Informatics 

    o   Latin America Drug Discovery Informatics by Mode

    §  In-house Informatics

    §  Outsourced Informatics 

    o   Latin America Drug Discovery Informatics by Service

    §  Sequencing and Target Data Analysis

    §  Docking

    §  Molecular Modeling

    §  Clinical Trial Data Management

    §  Others 

    Drug Discovery Informatics Market Report Research Report - Forecast Till 2030 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027